Press release
Primary Catalyst Driving Peptide And Oligonucleotide CDMO Market Evolution in 2025: Personalized Medicine Drives Growth In Peptide And Oligonucleotide CDMO Market Driver
Peptide And Oligonucleotide CDMO Market
The market size for peptide and oligonucleotide CDMO has seen significant expansion recently. The market is projected to escalate from $2.16 billion in 2024 to $2.42 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.1%. The historical growth pattern is largely due to an upsurge in the need for therapeutic agents, advancements in synthesis and manufacturing procedures, burgeoning personalized medicine trends, regulatory directives, and heightened attention on antiviral peptides and mRNA vaccines, emphasizing the role of oligonucleotides in vaccine production.
The size of the peptide and oligonucleotide cdmo market is predicted to surge significantly in the upcoming years, reaching a majestic sum of $3.79 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. This anticipated growth in the given time frame can be credited to factors like increasing interest in tailored medication, strides in biotechnology, extended applications, more outsourcing, and the escalating effects of chronic illnesses. The trend forecast for this phase involves elements like individualized treatments, advancements in technology, challenges in quality assurance, international expansion, and heightened collaboration among biotech pharmaceutical firms.
What Are the Key Drivers Behind the Growth of the Peptide And Oligonucleotide CDMO Market?
The surge in personalized medicine utilization is anticipated to spur the expansion of the peptide and oligonucleotide CDMO sectors. Personalized medicine is a healthcare approach that customizes medical treatments to individual traits, encompassing genetics, environment, and lifestyle. The upsurge in personalized medicine can be attributed to numerous factors like breakthroughs in genomic technologies, improved comprehension of disease processes at the molecular level, and the demand for more efficient and targeted treatment options based on patients' genetic makeups and medical backgrounds. Peptide and oligonucleotide contract development and manufacturing organizations (CDMOs) have a pivotal role in personalized medicine by creating bespoke therapeutic peptides and oligonucleotides specific to patient requirements. For instance, per the Personalized Medicine Coalition, a UK establishment advocating for personalized medicine use, the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) greenlit 16 new personalized treatments for patients with rare diseases in February 2024, an increase from 6 in 2022. Hence, the increasing adoption of personalized medicine is bolstering the growth of peptide and oligonucleotide CDMO markets.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15892&type=smp
Which Key Market Leaders Are Driving Peptide And Oligonucleotide CDMO Industry Growth?
Major companies operating in the peptide and oligonucleotide CDMO market are Thermo Fisher Scientific Inc., Merck KGaA, Ajinomoto Co. Inc., Lonza Group Ag, Wuxi Apptec Co. Ltd., Catalent Inc., Piramal Pharma Ltd., Curia Global Inc., Almac Group, Euroapi SA., CordenPharma International, Bachem Holding AG, Genscript Biotech Corporation, PolyPeptide Group, Rentschler Biopharma SE, Ambiopharm Inc., ScinoPharm, Senn Chemicals AG, Aurigene Pharmaceutical Services, Creative Peptides, Sylentis S.A.
What Are the Emerging Trends in the Peptide And Oligonucleotide CDMO Industry?
The primary participants in the peptide and oligonucleotide CDMO industry are striving to establish strategic alliances to bolster their service provisions, augment their technological prowess, and extend their market penetration. These alliances in peptide development and manufacturing are essentially cooperative arrangements between two entities concentrating on the creation and production of peptide-based treatments. For example, in May 2023, PolyPeptide Group AG, an American CDMO, forged a partnership with Numaferm GmbH, a biotech firm headquartered in Germany, focused on peptide development and production. The objective of this partnership is to leverage PolyPeptide's cGMP manufacturing capabilities and market penetration, in combination with Numaferm's mastery in sustainable peptide production and biochemical manufacturing platforms. Together, they intend to jointly investigate the development of appropriate peptide candidates with the aim of enhancing the sustainability of peptide-based API production.
What Are the Main Segments in the Peptide And Oligonucleotide CDMO Market?
The peptide and oligonucleotide cdmo market covered in this report is segmented -
1) By Product: Peptides, Oligonucleotides
2) By Service Type: Contract Development, Contract Manufacturing,
3) By Application: Therapeutics, Research Applications, Diagnostics, Other Applications
4) By End User: Biopharmaceutical Companies, Pharmaceutical Companies, Research Institutes, Academic and Government Organizations, Others End Users
Subsegments:
1) By Peptides: Active Pharmaceutical Ingredients (Apis), Peptide Drug Products, Peptide Synthesis And Manufacturing Services
2) By Oligonucleotides: Antisense Oligonucleotides, Sirna And Mrna Oligonucleotides, Oligonucleotide Synthesis And Manufacturing Services
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/peptide-and-oligonucleotide-cdmo-global-market-report
Which Geographic Area Leads the Peptide And Oligonucleotide CDMO Market?
North America was the largest region in the peptide and oligonucleotide CDMO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide and oligonucleotide cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Peptide And Oligonucleotide CDMO Global Market Report?
- Market Size Analysis: Analyze the Peptide And Oligonucleotide CDMO Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Peptide And Oligonucleotide CDMO Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Peptide And Oligonucleotide CDMO Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Peptide And Oligonucleotide CDMO Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15892
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving Peptide And Oligonucleotide CDMO Market Evolution in 2025: Personalized Medicine Drives Growth In Peptide And Oligonucleotide CDMO Market Driver here
News-ID: 3864780 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
